You searched for Antibody candidate - Page 8 of 67

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

…Less than a month after Lilly’s announcement, Biogen released positive data on its Phase 1b trial of aducanumab, an antibody candidate now in Phase III trials, reviving hopes for the…

January 31, 2017 - 7 minutesmins - By Diana Kwon

Best in Biotech 16 Jan 2025

Ten first-in-class drugs on track for FDA approval in 2025

…two main components: Monoclonal antibody (telisotuzumab): This antibody specifically binds to the c-Met protein on the surface of cancer cells. Cytotoxic agent (monomethyl auristatin E – MMAE): Once the antibody…

January 16, 2025 - 13 minutesmins - By Jules Adam

Numab Ono Pharmaceutical Immuno Oncology

News and Trends 28 Mar 2017

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

…sales, in exchange for the development of an immuno-oncology antibody candidate. For Numab, this deal with an oncology veteran certainly reinforces the potential of its antibody technology. The Japanese company…

March 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Ulrich dauer vivoryon alzheimers disease

Interview 23 Nov 2022

What recent mixed clinical results can teach about Alzheimer’s disease

…Abeta. Varoglutamstat also blocks the pathology earlier in the process than leading antibody candidates, and can be taken orally — a more convenient drug delivery than injecting or infusing antibody…

November 23, 2022 - 7 minutesmins - By Jonathan Smith

Best in Biotech 19 Aug 2025

10 biotech companies you should know about in Spain

…of antibody-drug conjugates (ADCs) that “exploit the molecular underpinnings” of advanced cancer. The company’s lead candidate is called ONA-255, which is a first-in-class ADC that is being developed to treat…

August 19, 2025 - 16 minutesmins - By Willow Shah-Neville

News and Trends 10 Aug 2022

Captor Therapeutics names lead candidate in fight against hepatocellular carcinoma

…of the lead drug candidate, Captor has initiated large scale synthesis with a reputable Contract Development and Manufacturing Organization. The CDMO will produce sufficient amounts of drug candidate to complete…

August 10, 2022 - 3 minutesmins - By Liza Laws

Best in Biotech 23 May 2025

Finland: Pushing biotech forward in the land of a thousand lakes

…the country’s landscape. Here are nine biotech companies pushing the industry forward in Finland. Table of contents Aplagon Foundation: 2009 Lead candidate: APAC Recent news: Secured a €7 million funding…

May 23, 2025 - 10 minutesmins - By Jules Adam

Best in Biotech 21 Mar 2024

Eight CAR-T cell therapy companies you should know about

…offering, American company CARGO Therapeutics has begun a phase 2 trial for its lead CAR-T cell therapy candidate CRG-022. The candidate targets CD22, a B-cell specific antigen that is expressed…

March 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 24 Jul 2024

Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market?

…advance the development of this candidate. This comes after the clinical evaluation of several modified-release once-daily formulations of danuglipron resulted in “encouraging pharmacokinetic data” for several candidates, with one showing…

July 24, 2024 - 10 minutesmins - By Willow Shah-Neville

In Depth 18 Feb 2025

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

…lurking? At present, there are a number of T cell engagers in the clinic. California-based Janux Therapeutics has two candidates in phase 1 trials. Its lead candidate JANX007 is designed…

February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 31 Mar 2020

Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant

…rights to develop and commercialize an immuno-oncology drug candidate for an unspecified indication using Numab’s multi-specific antibody platform, MATCH. Antibody-based therapies are becoming increasingly popular in oncology, with Merck’s approved…

March 31, 2020 - 3 minutesmins - By David Kirk

News and Trends 16 Jan 2017

German Antibody for Cancer Diagnostics catches an Australian Eye

…Wilex, in Germany, for the worldwide rights to Redectane, an antibody with diagnostic applications in renal cancer. The antibody, Rencarex (girentuximab), which binds to the CAIX antigen on clear cell…

January 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Biologicals on the Brain: Biotech in Neurodegenerative Disease

Ten first-in-class drugs on track for FDA approval in 2025

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

What recent mixed clinical results can teach about Alzheimer’s disease

10 biotech companies you should know about in Spain

Captor Therapeutics names lead candidate in fight against hepatocellular carcinoma

Finland: Pushing biotech forward in the land of a thousand lakes

Eight CAR-T cell therapy companies you should know about

Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market?

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant

German Antibody for Cancer Diagnostics catches an Australian Eye

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!